Tel Aviv University
Identifai-Genetics Closes $3.3M Post-Seed Fundraising Round
The Israeli startup said it is developing a liquid biopsy assay for the noninvasive detection of fetal genetic disorders during early pregnancy.
The grant was recently awarded through the EU's Cancer Mission, a funding program to reduce cancer cases throughout the EU by 2030.